Loxapine succinate is the succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent used as an active pharmaceutical ingredient. It acts by blocking dopamine receptors at postsynaptic sites in the limbic system, cortical system, and basal ganglia, reducing hallucinations and delusions associated with schizophrenia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 27833-64-3
Loxapine
pharmaceutical raw material
Amoxapine
pharmaceutical raw material
Nicergoline
pharmaceutical raw material
Chloramphenicol
pharmaceutical raw material
Imidocarb
pharmaceutical raw material
Levobunolol hydrochloride
pharmaceutical raw material
butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
YQZBAXDVDZTKEQ-UHFFFAOYSA-N
CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O